# COVID-19-дэ эсэргүү Pfizer–BioNTech вакцина
Comirnaty брэндээр зарагдажа байдаг, Pfizer–BioNTech COVID-19 вакцин (INN: tozinameran) — болбол Германиин BioNTech хампааниин бүтээһэн мРНХ-да һуурилһан COVID-19-дэ эсэргүү вакцина юм. Энэнь COVID-19-ые үүсхэдэг SARS-CoV-2 вирусай халдабариһаа хамгаалха зорилгоор зарим уласта 12 ба тэрэнһээ дээшэ наһанай, бусад уласта 16 ба тэрэнһээ дээшэ наһанай хүнүүдтэ хэрэглэхые зүбшөөрһэн. BioNTech нь вакцина бэлэдхэлгэдэ Америкын Pfizer хампаанитай клиникын туршалта, логистикэ, үйлэдбэрилгын шэглэлээр хамтаран ажаллаһан. Хитадта BioNTech нь Хитадай Fosun Pharma хампаанитай хамтаран хүгжөөлгэ, соносхол, эльгээхэ эрхын шэглэлээр ажалладаг ба вакциные Fosun–BioNTech COVID‑19 вакцина гэжэ хара хэлэндэ нэрлэһэн. Вакциные балсанда тариха замаар хэдэг.

## Эмнэлгын хэрэглэлгэ
Pfizer–BioNTech COVID-19 вакциные COVID-19-һээ уридшалан һэргылхэ, SARS-CoV-2 вирусай халдабариһаа хамгаалха зорилгоор ашагладаг. Вакциные "сагаанһаа шара-сагаан үнгэтэй, арюун, консервантгүй, балсан тарихада хүлдөөhэн" хэлбэреэр олон тунгаар хэһэн флакондо ниилүлэгдэдэг. Вакциные хэрэглэхэһээ үмэнэ таһалгын температура руу гэдхээжэ, дабһанай уусамалда шэнгэрүүлхэ хэрэгтэй.
Эхинэй курсынь хоёр дозоһоо бүридэхэ ба гурбадахи нэмэлтэ дозо зайлашагүй гэһэн баталалга байхагүй юм. Дэлхэйн Элүүр Мэндын Байгуулга (ДЭМБ) дозын хоорондо 3-4 долоон хоногой зайтай байхые зүблэжэ байна. Хоёрдохи дозые 12 долоон хоног хүрэтэр хойшолуулхань наhатай хүнүүдтэ иммунитет тогтохо шадабариие ехэдхэдэг ба Альфа хубилбариин эсэргүү нэгэдэхи дозын үрэ дүн 10 долоон хоног үргэлжэлдэг болохые харуулжа байна. Тиимэһээ хангамжа хизаарлагданги байгаа тохёолдолдо наһа баралтаһаа зайлахын тулада ДЭМБ-һаа нэн приоритетэй бүлэгүүдэдэ нэгэдэхи дозые үндэр олгохын тулада хоёрдохи дозые тариха хугасаае 12 долоон хоног хүрэтэр хойшолуулхые зүблэжэ байна.

### Үрэ дүн
| Хубилбари           | Хоёр дозо       | Хоёр дозо       | Хоёр дозо      | Нэгэ дозо       | Нэгэ дозо       | Нэгэ дозо     |
| Хубилбари           | Шэнжэ тэмдэггүй | Шэнжэ тэмдэгтэй | Госпитализаци  | Шэнжэ тэмдэггүй | Шэнжэ тэмдэгтэй | Госпитализаци |
| ------------------- | --------------- | --------------- | -------------- | --------------- | --------------- | ------------- |
| Бусад эрьежэ байһан | 92% (88–95%)    | 94% (87–98%)    | 87% (55–100%)  | 60% (53–66%)    | 66% (57–73%)    | 78% (61–91%)  |
| Альфа               | 90% (86–92%)    | 93% (90–96%)    | 95% (78–99%)   | 30% (23–36%)    | 49% (43–55%)    | 83% (62–93%)  |
| Бета                | 75% (71–79%)    | Not reported    | 100% (74–100%) | 17% (10–23%)    | Not reported    | 0% (0–19%)    |
| Гамма               | Not reported    | Not reported    | Not reported   | Not reported    | Not reported    | Not reported  |
| Дельта              | 79% (75–82%)    | 88% (78–93%)    | 96% (86–99%)   | 30% (17–41%)    | 33% (8–51%)     | 94% (46–99%)  |


## Түүхэ

### Зүбшөөрэл

#### Түргэдхэһэн
Нэгэдэһэн Хаанта Уласай Эм ба Элүүр Мэндын Бүтээгдэхүүные Гуримшуулха Агентлаг вакцинда 'халдабарита үбшэн зэргэ олониитын элүүр мэндын шухала асуудалнуудые шиидэхэ түр зуурын журамаар олгодог зүбшөөрэл'-ые 2020 оной 12 һарын 2-до олгоһон. Энэнь томо хэмжээнэй туршалга хииһэнэй дараа үндэһэнэй хэмжээндэ хэрэглэхые зүбшөөрһэн анханай COVID‑19-дэ эсэргүү вакцина ба хүндэ хэрэглэхэ зүбшөөрэл абаһан анханай РНХ-вакцина юм. Иихэлээрээ Нэгэдэһэн Хаанта уласиинь үндэһэнэй хэрэглээндэ зорюулагдаһан COVID‑19 вакциные баталһан анханай баруунай улас болоһон ба вакциные хурдан хугасаанда нэбтэрүүлхэ шиидхэбэриие зарим экспертүүд шүүмжэлжэ байһан.
Нэгэдэһэн Хаанта Уласай дараа удаахи улас ба бүһэ нютагнууд Pfizer–BioNTech COVID‑19 вакциные хэрэглэхэ зүбшөөрэлые олгохо ажалые хурдадхаһан: Аргентинэ, Австрали, Баhрэйн, Канада, Чили, Коста-Рика, Эквадор, Хонконг, Ирак, Израиль, Иордани, Кувейт, Малайзи, Мексикэ, Оман, Панама, Филиппина, Катар, Саудай Арави, Сингапур, Урда Солонгос, Арабай Нэгэдэһэн Эмиртэ Улас, АНУ ба Вьетнам.
Дэлхэйн Элүүр Мэндын Байгуулга (ДЭМБ) вакциные онсо яаралтай үедэ ашаглаха зүбшөөрэл олгоһон. АНУ-да аварийна үенэй зүбшөөрэл (EUA) — болбол "элүүр мэндын онсогой байдалай үедэ, жэшээнь мүнөөнэй COVID‑19 халдабарита үбшэн үедэ, вакциные нээлгээтэй, хэрэглэлгые хүнгэдхэхэ механизм" юм.

COVID-19-дэ эсэргүү Pfizer–BioNTech вакцина
'''Comirnaty''' брэндээр зарагдажа байдаг,<ref name="Comirnaty EPAR">{{cite web|title=Comirnaty EPAR|url=https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty|access-date=23 December 2020|website=[[European Medicines Agency]] (EMA)|archive-date=17 March 2021|archive-url=https://web.archive.org/web/20210317131756/https://www.ema.europa.eu/en/medicines/human/EPAR/comirnaty|url-status=live}}</ref> '''Pfizer–BioNTech COVID-19 вакцин''' ([[Уласхоорондын патентовалхагүй нэрлэлгэ|INN]]: '''tozinameran''') — болбол [[Германи|Германиин]] [[BioNTech]] хампааниин бүтээһэн [[РНХ-вакцина|мРНХ-да]] һуурилһан [[COVID-19-дэ эсэргүү вакцина]] юм. Энэнь [[COVID-19|COVID-19-ые]] үүсхэдэг [[SARS-CoV-2]] вирусай халдабариһаа хамгаалха зорилгоор<ref name="Comirnaty EPAR" /> зарим уласта 12 ба тэрэнһээ дээшэ наһанай, бусад уласта 16 ба тэрэнһээ дээшэ наһанай хүнүүдтэ хэрэглэхые зүбшөөрһэн.<ref>{{cite press release|title=First COVID-19 vaccine approved for children aged 12 to 15 in EU|website=[[European Medicines Agency]] (EMA)|date=28 May 2021|url=https://www.ema.europa.eu/en/news/first-covid-19-vaccine-approved-children-aged-12-15-eu|access-date=29 May 2021|archive-date=28 May 2021|archive-url=https://web.archive.org/web/20210528212329/https://www.ema.europa.eu/en/news/first-covid-19-vaccine-approved-children-aged-12-15-eu|url-status=live}}</ref><ref>{{cite web|title=Information for UK recipients on Pfizer/BioNTech COVID-19 vaccine|publisher=[[Medicines and Healthcare products Regulatory Agency]] (MHRA)|date=8 December 2020|url=https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-uk-recipients-on-pfizerbiontech-covid-19-vaccine|access-date=29 May 2021|archive-date=30 May 2021|archive-url=https://web.archive.org/web/20210530190316/https://www.gov.uk/government/publications/regulatory-approval-of-pfizer-biontech-vaccine-for-covid-19/information-for-uk-recipients-on-pfizerbiontech-covid-19-vaccine|url-status=live}}</ref> [[BioNTech]] нь вакцина бэлэдхэлгэдэ Америкын [[Pfizer]] хампаанитай [[клиникын туршалта]], логистикэ, үйлэдбэрилгын шэглэлээр хамтаран ажаллаһан.<ref>{{cite news|date=11 November 2020|title=What you need to know about BioNTech – the European company behind Pfizer's Covid-19 vaccine|publisher=CNBC|url=https://www.cnbc.com/2020/11/11/biontech-the-european-company-behind-pfizers-covid-19-vaccine.html|access-date=14 January 2021|vauthors=Browne R|archive-date=4 March 2021|archive-url=https://web.archive.org/web/20210304192058/https://www.cnbc.com/2020/11/11/biontech-the-european-company-behind-pfizers-covid-19-vaccine.html|url-status=live}}</ref> Хитадта BioNTech нь Хитадай [[Fosun Pharma]] хампаанитай хамтаран хүгжөөлгэ, соносхол, эльгээхэ эрхын шэглэлээр ажалладаг ба вакциные '''Fosun–BioNTech COVID‑19 вакцина''' гэжэ хара хэлэндэ нэрлэһэн.<ref name="Fosun PR 20201216">{{cite press release|title=BioNTech and Fosun Pharma to Supply China with mRNA-based COVID-19 Vaccine|url=https://www.fosunpharma.com/en/news/news-details-3820.html|date=16 December 2020|access-date=2021-04-18|publisher=Fosun Pharma|archive-date=18 April 2021|archive-url=https://web.archive.org/web/20210418144020/https://www.fosunpharma.com/en/news/news-details-3820.html|url-status=live}}</ref><ref>{{cite news|title=BioNTech in China alliance with Fosun over potential coronavirus vaccine|date=16 March 2020|url=https://www.reuters.com/article/us-biontech-fosunpharma-vaccine-collabor-idUKKBN2130O5|access-date=19 March 2021|work=Reuters|quote=BioNTech struck a collaboration deal with Shanghai Fosun Pharmaceutical over the German biotech firm's rights in China to an experimental coronavirus vaccine, the latest gambit in a global race to halt the pandemic.|vauthors=Burger L|archive-date=14 April 2021|archive-url=https://web.archive.org/web/20210414205227/https://www.reuters.com/article/us-biontech-fosunpharma-vaccine-collabor-idUKKBN2130O5|url-status=live}}</ref><ref>{{cite news|title=BioNTech, Fosun start Phase II trial of COVID-19 vaccine in China|date=25 November 2020|url=https://www.reuters.com/article/us-health-coronavirus-biontech-fosunphar-idUSKBN2850ZZ|access-date=20 March 2021|work=Reuters|quote=BioNTech and Shanghai Fosun Pharmaceutical said on Wednesday they would launch a Phase{{nbs}}II clinical trial of BioNTech's experimental COVID-19 vaccine in China.|archive-date=14 April 2021|archive-url=https://web.archive.org/web/20210414205231/https://www.reuters.com/article/us-health-coronavirus-biontech-fosunphar-idUSKBN2850ZZ|url-status=live}}</ref><ref name="Fosun PR 20210227">{{cite press release|title=BioNTech and Fosun Pharma Jointly Announce the Arrival of the First Batch of COVID-19 mRNA Vaccine in Hong Kong and Macau|publisher=[[Fosun Pharma]]|date=27 February 2021|url=https://www.fosunpharma.com/en/news/news-details-3829.html|access-date=15 April 2021|archive-date=15 April 2021|archive-url=https://web.archive.org/web/20210415191727/https://www.fosunpharma.com/en/news/news-details-3829.html|url-status=live}}</ref><ref>{{cite news|title=BioNTech and China partner, not Pfizer, to produce HK shots|url=https://www.thestandard.com.hk/section-news/section/11/225661/BioNTech-and-China-partner,-not-Pfizer,-to-produce-HK-shots|website=[[The Standard (Hong Kong)|The Standard]]|date=14 December 2020|access-date=18 April 2021|archive-date=18 April 2021|archive-url=https://web.archive.org/web/20210418142309/https://www.thestandard.com.hk/section-news/section/11/225661/BioNTech-and-China-partner,-not-Pfizer,-to-produce-HK-shots|url-status=live}}</ref> Вакциные балсанда тариха замаар хэдэг.

== Эмнэлгын хэрэглэлгэ ==
Pfizer–BioNTech COVID-19 вакциные COVID-19-һээ уридшалан һэргылхэ, [[SARS-CoV-2]] вирусай халдабариһаа хамгаалха зорилгоор ашагладаг. Вакциные "сагаанһаа шара-сагаан үнгэтэй, арюун, консервантгүй, балсан тарихада хүлдөөhэн" хэлбэреэр олон тунгаар хэһэн флакондо ниилүлэгдэдэг. Вакциные хэрэглэхэһээ үмэнэ таһалгын температура руу гэдхээжэ, [[Дабһанай уусамал|дабһанай уусамалда]] шэнгэрүүлхэ хэрэгтэй.

Эхинэй курсынь хоёр дозоһоо бүридэхэ ба гурбадахи нэмэлтэ дозо зайлашагүй гэһэн баталалга байхагүй юм. [[Дэлхэйн элүүр мэндын байгуулга|Дэлхэйн Элүүр Мэндын Байгуулга]] (ДЭМБ) дозын хоорондо 3-4 долоон хоногой зайтай байхые зүблэжэ байна. Хоёрдохи дозые 12 долоон хоног хүрэтэр хойшолуулхань наhатай хүнүүдтэ иммунитет тогтохо шадабариие ехэдхэдэг ба [[SARS-CoV-2-ай Альфа хубилбари|Альфа хубилбариин]] эсэргүү нэгэдэхи дозын үрэ дүн 10 долоон хоног үргэлжэлдэг болохые харуулжа байна. Тиимэһээ хангамжа хизаарлагданги байгаа тохёолдолдо наһа баралтаһаа зайлахын тулада ДЭМБ-һаа нэн приоритетэй бүлэгүүдэдэ нэгэдэхи дозые үндэр олгохын тулада хоёрдохи дозые тариха хугасаае 12 долоон хоног хүрэтэр хойшолуулхые зүблэжэ байна.<ref name="who-guidance">{{cite techreport|type=Guidance|title=Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing|id=WHO/2019-nCoV/vaccines/SAGE_recommendation//BNT162b2/2021.2|institution=World Health Organization|date=15 June 2021|url=https://www.who.int/publications/i/item/WHO-2019-nCoV-vaccines-SAGE_recommendation-BNT162b2-2021.1}}</ref>

=== Үрэ дүн ===
{| class="wikitable sortable"
|+Үбшэнэй хүндын зэргээр үрэ дүнтэй байдал
! rowspan="2" |[[SARS-CoV-2-ай хубилбаригууд|Хубилбари]]
! colspan="3" |Хоёр дозо
! colspan="3" |Нэгэ дозо
|-
!Шэнжэ тэмдэггүй
!Шэнжэ тэмдэгтэй
!Госпитализаци
!Шэнжэ тэмдэггүй
!Шэнжэ тэмдэгтэй
!Госпитализаци
|-
|Бусад эрьежэ байһан
|{{good|{{Estimate|92|88|95|unit=%|mini=auto}}<ref>{{cite journal |vauthors=Dagan N, Barda N, Kepten E, Miron O, Perchik S, Katz MA, Hernán MA, Lipsitch M, Reis B, Balicer RD |display-authors=6 |date=April 2021 |title=BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting |journal=New England Journal of Medicine |volume=384 |issue=15 |at=Table 2 |doi=10.1056/NEJMoa2101765 |pmc=7944975 |pmid=33626250}}</ref>|align=left}}
|{{good|{{Estimate|94|87|98|unit=%|mini=auto}}|align=left}}
|{{good|{{Estimate|87|55|100|unit=%|mini=auto}}|align=left}}
|{{good|{{Estimate|60|53|66|unit=%|mini=auto}}|align=left}}
|{{good|{{Estimate|66|57|73|unit=%|mini=auto}}|align=left}}
|{{good|{{Estimate|78|61|91|unit=%|mini=auto}}|align=left}}
|-
|[[SARS-CoV-2-ай Альфа хубилбари|Альфа]]
|{{good|{{Estimate|90|86|92|unit=%|mini=auto}}<ref name=":2">{{cite journal |vauthors=Abu-Raddad LJ, Chemaitelly H, Butt AA |title=Effectiveness of the BNT162b2 Covid-19 Vaccine against the B.1.1.7 and B.1.351 Variants |at=Table 1 |journal=New England Journal of Medicine |date=5 May 2021 |pmid=33951357 |pmc=8117967 |doi=10.1056/NEJMc2104974 |doi-access=free |url=https://www.nejm.org/doi/full/10.1056/NEJMc2104974 }}</ref>|align=left}}
|{{good|{{Estimate|93|90|96|unit=%|mini=yes}}<ref>{{cite journal |vauthors=Bernal JL, Andrews N, Gower C, Gallagher E, Simmons R, Thelwall S, Stowe J, Tessier E, Groves N, Dabrera G, Myers R |display-authors=6 |date=2021-05-24 |title=Effectiveness of COVID-19 vaccines against the B.1.617.2 variant |at=Table 2 |url=https://www.medrxiv.org/content/10.1101/2021.05.22.21257658v1 |via=[[medRxiv]] |type=[[Preprint]] |doi=10.1101/2021.05.22.21257658}}</ref><ref name="briefing17">{{cite techreport |type=Briefing |title=SARS-CoV-2 variants of concern and variants under investigation in England, technical briefing 17 |id=GOV-8576 |institution=Public Health England |date=2021-06-25 |url=https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/996740/Variants_of_Concern_VOC_Technical_Briefing_17.pdf |format=PDF |access-date=2021-06-26}}</ref>|align=left}}
|{{good|{{Estimate|95|78|99|unit=%|mini=auto}}|align=left}}
|{{Estimate|30|23|36|unit=%|mini=auto}}
|{{Estimate|49|43|55|unit=%|mini=auto}}
|{{good|{{Estimate|83|62|93|unit=%|mini=auto}}|align=left}}
|-
|[[SARS-CoV-2-ай Бета хубилбари|Бета]]
|{{good|{{Estimate|75|71|79|unit=%|mini=auto}}<ref name=":2" />|align=left}}
|{{n/a|Not reported}}
|{{good|{{Estimate|100|74|100|unit=%|mini=auto}}<ref name=":2"/>|align=left}}
|{{Estimate|17|10|23|unit=%|mini=auto}}
|{{n/a|Not reported}}
|{{Estimate|0|0|19|unit=%|mini=auto}}
|-
|[[SARS-CoV-2-ай Гамма хубилбари|Гамма]]
|{{n/a|Not reported}}
|{{n/a|Not reported}}
|{{n/a|Not reported}}
|{{n/a|Not reported}}
|{{n/a|Not reported}}
|{{n/a|Not reported}}
|-
|[[SARS-CoV-2-ай Дельта хубилбари|Дельта]]
|{{good|{{Estimate|79|75|82|unit=%|mini=auto}}<ref name="effectiveness-scotland">{{cite journal |vauthors=Sheikh A, McMenamin J, Taylor B, Robertson C |date=2021-06-14 |title=SARS-CoV-2 Delta VOC in Scotland: demographics, risk of hospital admission, and vaccine effectiveness |at=Table S4 |url=https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01358-1/abstract |journal=The Lancet |doi=10.1016/S0140-6736(21)01358-1 |issn=0140-6736 |pmid=34139198|pmc=8201647 }}</ref>|align=left}}
|{{good|{{Estimate|88|78|93|unit=%|mini=auto}}|align=left}}
|{{good|{{Estimate|96|86|99|unit=%|mini=auto}}<ref>{{cite techreport |type=[[Preprint]] |via=Knowledge Hub |vauthors=Stowe J, Andrews N, Gower C, Gallagher E, Utsi L, Simmons R, Thelwall S, Tessier E, Groves N, Dabrera G, Myers R, Campbell C, Amirthalingam G, Edmunds M, Zambon M, Brown K, Hopkins S, Chand M, Ramsay M, Bernal JL |display-authors=6 |title=Effectiveness of COVID-19 vaccines against hospital admission with the Delta (B.1.617.2) variant |at=Table 1 |institution=Public Health England |date=2021-06-14 |url=https://khub.net/documents/135939561/479607266/Effectiveness+of+COVID-19+vaccines+against+hospital+admission+with+the+Delta+%28B.1.617.2%29+variant.pdf/1c213463-3997-ed16-2a6f-14e5deb0b997?t=1623689315431}}</ref><ref name="briefing17"/>|align=left}}
|{{Estimate|30|17|41|unit=%|mini=auto}}
|{{Estimate|33|8|51|unit=%|mini=auto}}
|{{good|{{Estimate|94|46|99|unit=%|mini=auto}}|align=left}}
|}

== Түүхэ ==

=== Зүбшөөрэл ===
{{#section:COVID-19-дэ эсэргүй вакцинай зүбшөөрэлэй жагсаалта|pfizerauthmap}}
{{See also|COVID-19-дэ эсэргүй вакцинай зүбшөөрэлэй жагсаалта#Pfizer–BioNTech}}

==== Түргэдхэһэн ====
Нэгэдэһэн Хаанта Уласай [[Эм ба Элүүр Мэндын Бүтээгдэхүүные Гуримшуулха Агентлаг]] вакцинда 'халдабарита үбшэн зэргэ олониитын элүүр мэндын шухала асуудалнуудые шиидэхэ түр зуурын журамаар олгодог зүбшөөрэл'-ые 2020 оной 12 һарын 2-до олгоһон. Энэнь томо хэмжээнэй туршалга хииһэнэй дараа үндэһэнэй хэмжээндэ хэрэглэхые зүбшөөрһэн анханай COVID‑19-дэ эсэргүү вакцина<ref>{{cite news|url=https://apnews.com/article/uk-authorizes-vaccine-emergency-use-ea0170c978eb281a905866e5bd78bbdf|title=Britain OKs Pfizer vaccine and will begin shots within days|publisher=Associated Press|date=2 December 2020|vauthors=Neergaard L, Kirka D|access-date=6 December 2020|archive-date=6 December 2020|archive-url=https://web.archive.org/web/20201206161358/https://apnews.com/article/uk-authorizes-vaccine-emergency-use-ea0170c978eb281a905866e5bd78bbdf|url-status=live}}</ref> ба хүндэ хэрэглэхэ зүбшөөрэл абаһан анханай [[РНХ-вакцина]] юм.<ref name="mueller">{{cite news|vauthors=Mueller B|title=U.K. Approves Pfizer Coronavirus Vaccine, a First in the West|url=https://www.nytimes.com/2020/12/02/world/europe/pfizer-coronavirus-vaccine-approved-uk.html|access-date=2 December 2020|work=The New York Times|date=2 December 2020|archive-date=28 January 2021|archive-url=https://web.archive.org/web/20210128124416/https://www.nytimes.com/2020/12/02/world/europe/pfizer-coronavirus-vaccine-approved-uk.html|url-status=live}}</ref> Иихэлээрээ Нэгэдэһэн Хаанта уласиинь үндэһэнэй хэрэглээндэ зорюулагдаһан COVID‑19 вакциные баталһан анханай баруунай улас болоһон<ref name="bbcuk">{{cite news|date=2 December 2020|title=Covid Pfizer vaccine approved for use next week in UK|vauthors=Roberts M|work=[[BBC News]]|url=https://www.bbc.com/news/health-55145696|access-date=2 December 2020|archive-date=2 December 2020|archive-url=https://web.archive.org/web/20201202070718/https://www.bbc.com/news/health-55145696|url-status=live}}</ref> ба вакциные хурдан хугасаанда нэбтэрүүлхэ шиидхэбэриие зарим экспертүүд шүүмжэлжэ байһан.<ref>{{cite news|url=https://www.theguardian.com/world/2020/dec/03/europe-us-experts-question-uk-fast-track-covid-vaccine|title=European and US experts question UK's fast-track of Covid vaccine|date=3 December 2020|vauthors=Henley J, Connolly, Jones S|website=The Guardian|access-date=9 December 2020|archive-date=9 December 2020|archive-url=https://web.archive.org/web/20201209004141/https://www.theguardian.com/world/2020/dec/03/europe-us-experts-question-uk-fast-track-covid-vaccine|url-status=live}}</ref>

Нэгэдэһэн Хаанта Уласай дараа удаахи улас ба бүһэ нютагнууд Pfizer–BioNTech COVID‑19 вакциные хэрэглэхэ зүбшөөрэлые олгохо ажалые хурдадхаһан: Аргентинэ,<ref>{{cite news|url=https://www.lanacion.com.ar/sociedad/coronavirus-argentina-anmat-aprobo-uso-emergencia-vacuna-nid2548852|title=Coronavirus en la Argentina: La ANMAT aprobo el uso de emergencia de la vacuna Pfizer|access-date=25 December 2020|newspaper=La Nación|language=es|archive-date=26 January 2021|archive-url=https://web.archive.org/web/20210126205219/https://www.lanacion.com.ar/sociedad/coronavirus-argentina-anmat-aprobo-uso-emergencia-vacuna-nid2548852|url-status=live}}</ref> Австрали,<ref>{{cite press release|title=TGA provisionally approves Pfizer COVID-19 vaccine|website=[[Therapeutic Goods Administration]]|url=https://www.tga.gov.au/media-release/tga-provisionally-approves-pfizer-covid-19-vaccine|date=25 January 2021|access-date=26 January 2021|archive-date=26 January 2021|archive-url=https://web.archive.org/web/20210126071449/https://www.tga.gov.au/media-release/tga-provisionally-approves-pfizer-covid-19-vaccine|url-status=live}}</ref> Баhрэйн,<ref>{{cite web|title=Bahrain becomes second country to approve Pfizer COVID-l19 vaccine|url=https://www.aljazeera.com/news/2020/12/4/bahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine|publisher=[[Al Jazeera]]|date=4 December 2020|archive-date=4 December 2020|archive-url=https://web.archive.org/web/20201204211007/https://www.aljazeera.com/news/2020/12/4/bahrain-becomes-second-country-to-approve-pfizer-covid-19-vaccine|url-status=live}}</ref> Канада,<ref name="CA Pfizer-BioNTech product description">{{cite web|title=Pfizer–BioNTech COVID-19 Vaccine (tozinameran)|url=https://covid-vaccine.canada.ca/pfizer-biontech-covid-19-vaccine/product-details|publisher=[[Health Canada]]|access-date=15 December 2020|archive-date=16 December 2020|archive-url=https://web.archive.org/web/20201216003438/https://covid-vaccine.canada.ca/pfizer-biontech-covid-19-vaccine/product-details|url-status=live}}</ref><ref name="canlist">{{cite web|date=9 December 2020|title=Drug and vaccine authorizations for COVID-19: List of applications received|url=https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/applications.html|access-date=9 December 2020|publisher=[[Health Canada]]|archive-date=18 March 2021|archive-url=https://web.archive.org/web/20210318002401/https://www.canada.ca/en/health-canada/services/drugs-health-products/covid19-industry/drugs-vaccines-treatments/authorization/applications.html|url-status=live}}</ref> Чили,<ref name="El Pais">{{cite web|title=Chile y Ecuador se adelantan en Sudamérica y autorizan la vacuna de Pfizer|date=16 December 2020|url=https://elpais.com/sociedad/2020-12-16/chile-y-ecuador-se-adelantan-en-sudamerica-y-autorizan-la-vacuna-de-pfizer.html|publisher=El Pais|access-date=17 December 2020|archive-date=16 December 2020|archive-url=https://web.archive.org/web/20201216222640/https://elpais.com/sociedad/2020-12-16/chile-y-ecuador-se-adelantan-en-sudamerica-y-autorizan-la-vacuna-de-pfizer.html|url-status=live}}</ref> Коста-Рика,<ref>{{cite news|date=23 December 2020|title=First Pfizer COVID-19 vaccines set to reach Costa Rica on Wednesday – president|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-costarica-vaccine-idUSS0N2HB06S|access-date=24 December 2020|archive-date=9 March 2021|archive-url=https://web.archive.org/web/20210309150520/https://www.reuters.com/article/health-coronavirus-costarica-vaccine-idUSS0N2HB06S|url-status=live}}</ref> Эквадор, Хонконг,<ref>{{cite press release|title=SFH authorises COVID-19 vaccine by Fosun Pharma/BioNTech for emergency use in Hong Kong|website=[[The Government of Hong Kong]]|url=https://www.info.gov.hk/gia/general/202101/25/P2021012500829.htm|date=25 January 2021|access-date=26 January 2021|archive-date=19 March 2021|archive-url=https://web.archive.org/web/20210319090956/https://www.info.gov.hk/gia/general/202101/25/P2021012500829.htm|url-status=live}}</ref> Ирак,<ref name="msn.com">{{cite web|title=Iraq grants emergency approval for Pfizer COVID-19 vaccine|url=https://www.msn.com/en-ae/news/other/iraq-grants-emergency-approval-for-pfizer-covid-19-vaccine/ar-BB1cgvD6|access-date=27 December 2020|publisher=MSN|archive-date=8 January 2021|archive-url=https://web.archive.org/web/20210108101400/https://www.msn.com/en-ae/news/other/iraq-grants-emergency-approval-for-pfizer-covid-19-vaccine/ar-BB1cgvD6|url-status=live}}</ref> Израиль,<ref>{{cite web|title=Israeli Health Minister 'pleased' as FDA approves Pfizer COVID-19 vaccine|url=https://www.jpost.com/breaking-news/fda-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use-nyt-651871|access-date=28 December 2020|website=The Jerusalem Post|archive-date=19 March 2021|archive-url=https://web.archive.org/web/20210319104432/https://www.jpost.com/breaking-news/fda-approves-pfizer-biontech-covid-19-vaccine-for-emergency-use-nyt-651871|url-status=live}}</ref> Иордани,<ref>{{cite web|access-date=15 December 2020|title=Jordan approves Pfizer–BioNTech Covid vaccine|url=https://www.france24.com/en/live-news/20201215-jordan-approves-pfizer-biontech-covid-vaccine|date=15 December 2020|publisher=France 24|archive-date=9 March 2021|archive-url=https://web.archive.org/web/20210309150527/https://www.france24.com/en/live-news/20201215-jordan-approves-pfizer-biontech-covid-vaccine|url-status=live}}</ref> Кувейт,<ref>{{cite web|access-date=15 December 2020|title=Kuwait authorizes emergency use of Pfizer–BioNTech COVID-19 vaccine|url=https://arab.news/427j9|date=13 December 2020|website=Arab News|archive-date=19 March 2021|archive-url=https://web.archive.org/web/20210319120421/https://www.arabnews.com/node/1776666/middle-east|url-status=live}}</ref> Малайзи,<ref>{{cite web|url=https://codeblue.galencentre.org/2021/01/08/malaysias-npra-approves-pfizer-covid-19-vaccine/|title=Malaysia's NPRA Approves Pfizer Covid-19 Vaccine|publisher=CodeBlue|date=8 January 2021|access-date=25 February 2021|archive-date=20 January 2021|archive-url=https://web.archive.org/web/20210120091910/https://codeblue.galencentre.org/2021/01/08/malaysias-npra-approves-pfizer-covid-19-vaccine/|url-status=live}}</ref> Мексикэ,<ref>{{cite news|vauthors=Solomon DB, Torres N|title=Mexico approves emergency use of Pfizer's COVID-19 vaccine|url=https://www.reuters.com/article/us-health-coronavirus-mexico-idUSKBN28M019|work=[[Reuters]]|date=11 December 2020|access-date=14 December 2020|archive-date=15 January 2021|archive-url=https://web.archive.org/web/20210115173149/https://www.reuters.com/article/us-health-coronavirus-mexico-idUSKBN28M019|url-status=live}}</ref><ref>{{cite news|date=12 December 2020|title=Mexico Approves Pfizer Vaccine for Emergency Use as Covid Surges|work=Bloomberg|url=https://www.bloomberg.com/news/articles/2020-12-12/mexico-approves-pfizer-vaccine-for-emergency-use-as-covid-surges|access-date=12 December 2020|archive-date=8 January 2021|archive-url=https://web.archive.org/web/20210108043302/https://www.bloomberg.com/news/articles/2020-12-12/mexico-approves-pfizer-vaccine-for-emergency-use-as-covid-surges|url-status=live}}</ref> Оман,<ref name="oman">{{cite news|date=15 December 2020|title=Oman issues licence to import Pfizer BioNTech Covid vaccine – TV|publisher=Reuters|url=https://www.reuters.com/article/health-coronavirus-oman-vaccine-int-idUSKBN28P1RA|access-date=16 December 2020|archive-date=9 March 2021|archive-url=https://web.archive.org/web/20210309150457/https://www.reuters.com/article/health-coronavirus-oman-vaccine-int-idUSKBN28P1RA|url-status=live}}</ref> Панама,<ref name="panama">{{cite news|title=Panama approves Pfizer's COVID-19 vaccine – health ministry|url=https://www.reuters.com/article/health-coronavirus-panama/panama-approves-pfizers-covid-19-vaccine-health-ministry-idUSS0N2HB06H|vauthors=Moreno E|work=[[Reuters]]|date=15 December 2020|access-date=8 May 2021|archive-date=8 February 2021|archive-url=https://web.archive.org/web/20210208234438/https://www.reuters.com/article/health-coronavirus-panama/panama-approves-pfizers-covid-19-vaccine-health-ministry-idUSS0N2HB06H|url-status=live}}</ref> Филиппина,<ref>{{cite news|date=14 January 2021|title=PH authorizes Pfizer's COVID-19 vaccine for emergency use|work=CNN Philippines|url=https://cnnphilippines.com/news/2021/1/14/Pfizer-COVID-19-vaccine-Philippines-FDA-emergency-use-EUA.html|access-date=21 January 2021|archive-date=27 February 2021|archive-url=https://web.archive.org/web/20210227101930/https://cnnphilippines.com/news/2021/1/14/Pfizer-COVID-19-vaccine-Philippines-FDA-emergency-use-EUA.html|url-status=live|accessdate=9 July 2021|archivedate=27 February 2021|archiveurl=https://web.archive.org/web/20210227101930/https://cnnphilippines.com/news/2021/1/14/Pfizer-COVID-19-vaccine-Philippines-FDA-emergency-use-EUA.html}}</ref> Катар,<ref>{{cite news|access-date=24 December 2020|title=Qatar, Oman to receive Pfizer–BioNTech COVID-19 vaccine this week|date=21 December 2020|url=https://www.reuters.com/article/us-health-coronavirus-vaccine-qatar/qatar-oman-to-receive-pfizer-biontech-covid-19-vaccine-this-week-idUSKBN28U0VE|work=Reuters|archive-date=9 March 2021|archive-url=https://web.archive.org/web/20210309150503/https://www.reuters.com/article/us-health-coronavirus-vaccine-qatar/qatar-oman-to-receive-pfizer-biontech-covid-19-vaccine-this-week-idUSKBN28U0VE|url-status=live}}</ref> Саудай Арави,<ref>{{cite web|date=10 December 2020|title=Coronavirus: Saudi Arabia approves Pfizer COVID-19 vaccine for use|url=https://english.alarabiya.net/en/coronavirus/2020/12/10/Coronavirus-Saudi-Arabia-approves-Pfizer-COVID-19-vaccine-for-use|access-date=10 December 2020|website=Al Arabiya English|archive-date=11 December 2020|archive-url=https://web.archive.org/web/20201211155342/https://english.alarabiya.net/en/coronavirus/2020/12/10/Coronavirus-Saudi-Arabia-approves-Pfizer-COVID-19-vaccine-for-use|url-status=live}}</ref><ref name="mulla">{{cite news|vauthors=Al Mulla Y|title=Kuwait approves emergency use of Pfizer vaccine|url=https://gulfnews.com/world/gulf/kuwait/kuwait-approves-emergency-use-of-pfizer-vaccine-1.75875294|work=[[Gulf News]]|date=13 December 2020|access-date=14 December 2020|archive-date=14 December 2020|archive-url=https://web.archive.org/web/20201214125031/https://gulfnews.com/world/gulf/kuwait/kuwait-approves-emergency-use-of-pfizer-vaccine-1.75875294|url-status=live}}</ref><ref>{{cite web|title=Saudi Arabia to Launch Its Coronavirus Vaccination Program|url=https://www.bloomberg.com/news/articles/2020-12-15/saudi-arabia-to-launch-its-coronavirus-vaccination-program|publisher=Boomberg|access-date=17 December 2020|language=es|url-status=live}}</ref> Сингапур,<ref>{{cite web|title=First shipments of Pfizer–BioNTech vaccine in Singapore by end-Dec; enough vaccines for all by Q3 2021|url=https://www.straitstimes.com/singapore/health/first-shipments-of-pfizer-biontech-vaccine-in-singapore-by-end-dec-enough-vaccines|date=14 December 2020|website=The Straits Times|access-date=14 December 2020|archive-date=14 December 2020|archive-url=https://web.archive.org/web/20201214091234/https://www.straitstimes.com/singapore/health/first-shipments-of-pfizer-biontech-vaccine-in-singapore-by-end-dec-enough-vaccines|url-status=live}}</ref><ref>{{cite web|vauthors=Abdullah Z|title=Pfizer–BioNTech COVID-19 vaccine approved by Singapore, first shipment expected by end-December|url=https://www.channelnewsasia.com/news/singapore/singapore-approves-pfizer-biontech-covid-19-vaccine-phase-3-13769570|website=CNA|access-date=16 January 2021|date=14 December 2020|archive-date=4 February 2021|archive-url=https://web.archive.org/web/20210204082015/https://www.channelnewsasia.com/news/singapore/singapore-approves-pfizer-biontech-covid-19-vaccine-phase-3-13769570|url-status=live|accessdate=9 July 2021|archivedate=4 February 2021|archiveurl=https://web.archive.org/web/20210204082015/https://www.channelnewsasia.com/news/singapore/singapore-approves-pfizer-biontech-covid-19-vaccine-phase-3-13769570}}</ref><ref>{{cite web|access-date=15 December 2020|title=Singapore approves use of Pfizer's COVID-19 vaccine|url=https://apnews.com/article/science-singapore-coronavirus-pandemic-lee-hsien-loong-coronavirus-vaccine-5bf8461b9d2d32ec08d56fcf5958317a|date=14 December 2020|website=AP News|archive-date=22 January 2021|archive-url=https://web.archive.org/web/20210122101951/https://apnews.com/article/science-singapore-coronavirus-pandemic-lee-hsien-loong-coronavirus-vaccine-5bf8461b9d2d32ec08d56fcf5958317a|url-status=live}}</ref> Урда Солонгос,<ref>{{cite news|vauthors=Lim JY|date=3 February 2021|title=South Korea approves special import of Pfizer vaccine|url=http://www.koreaherald.com/view.php?ud=20210203001122|access-date=28 February 2021|work=The Korea Heral|archive-date=16 February 2021|archive-url=https://web.archive.org/web/20210216020623/http://www.koreaherald.com/view.php?ud=20210203001122|url-status=live}}</ref><ref>{{cite news|vauthors=Lee K|date=27 February 2021|title=S. Korea begins rolling out Pfizer vaccines on second day of national vaccination program|url=https://www.arirang.com/news/News_View.asp?nseq=273056|access-date=28 February 2021|work=Arirang News|archive-date=10 March 2021|archive-url=https://web.archive.org/web/20210310013846/https://www.arirang.com/news/News_View.asp?nseq=273056|url-status=live|accessdate=9 July 2021|archivedate=10 March 2021|archiveurl=https://web.archive.org/web/20210310013846/https://www.arirang.com/news/News_View.asp?nseq=273056}}</ref> Арабай Нэгэдэһэн Эмиртэ Улас,<ref name="emirateswoman.com">{{cite web|date=23 December 2020|title=Dubai approves the Pfizer–BioNTech vaccine which will be free of charge|url=https://emirateswoman.com/dubai-approves-the-pfizer-biontech-vaccine-for-free/|access-date=28 December 2020|website=Emirates Woman|archive-date=31 January 2021|archive-url=https://web.archive.org/web/20210131135503/https://emirateswoman.com/dubai-approves-the-pfizer-biontech-vaccine-for-free/|url-status=live}}</ref> АНУ ба Вьетнам.<ref>{{cite web|url=https://e.vnexpress.net/news/news/vietnam-approves-pfizer-covid-vaccine-for-emergency-use-4293267.html|title=Vietnam approves Pfizer Covid vaccine for emergency use|vauthors=Nga L|publisher=VnExpress|date=12 June 2021|accessdate=15 June 2021|archive-url=https://web.archive.org/web/20210615091636/https://e.vnexpress.net/news/news/vietnam-approves-pfizer-covid-vaccine-for-emergency-use-4293267.html|archive-date=15 June 2021|url-status=live}}</ref>

[[Дэлхэйн элүүр мэндын байгуулга|Дэлхэйн Элүүр Мэндын Байгуулга]] (ДЭМБ) вакциные онсо яаралтай үедэ ашаглаха зүбшөөрэл олгоһон.<ref>{{cite press release|title=WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access|website=[[World Health Organization]] (WHO)|url=https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access|date=31 December 2020|access-date=6 January 2021|archive-date=17 March 2021|archive-url=https://web.archive.org/web/20210317043909/https://www.who.int/news/item/31-12-2020-who-issues-its-first-emergency-use-validation-for-a-covid-19-vaccine-and-emphasizes-need-for-equitable-global-access|url-status=live}}</ref><ref>{{cite web|title=WHO recommendation BioNtech Tozinameran – COVID-19 mRNA vaccine (nucleoside modified) – Comirnaty|website=[[World Health Organization]] (WHO)|date=31 December 2020|url=https://extranet.who.int/pqweb/vaccines/who-recommendation-covid-19-mrna-vaccine-nucleoside-modified-comirnaty|access-date=30 May 2021|archive-date=9 May 2021|archive-url=https://web.archive.org/web/20210509155424/https://extranet.who.int/pqweb/vaccines/who-recommendation-covid-19-mrna-vaccine-nucleoside-modified-comirnaty|url-status=live|accessdate=9 July 2021|archivedate=9 May 2021|archiveurl=https://web.archive.org/web/20210509155424/https://extranet.who.int/pqweb/vaccines/who-recommendation-covid-19-mrna-vaccine-nucleoside-modified-comirnaty}}</ref> АНУ-да [[аварийна үенэй зүбшөөрэл]] (EUA) — болбол "элүүр мэндын онсогой байдалай үедэ, жэшээнь мүнөөнэй COVID‑19 халдабарита үбшэн үедэ, вакциные нээлгээтэй, хэрэглэлгые хүнгэдхэхэ механизм" юм.<ref name="fda-eua">{{cite web|title=Emergency Use Authorization for vaccines explained|website=U.S. [[Food and Drug Administration]] (FDA)|date=20 November 2020|url=https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained|access-date=20 November 2020|archive-date=20 November 2020|archive-url=https://web.archive.org/web/20201120184730/https://www.fda.gov/vaccines-blood-biologics/vaccines/emergency-use-authorization-vaccines-explained|url-status=live}} {{PD-notice}}</ref>

== Зүүлтэ ==
<references responsive="" />

== Холбоо ==

[[Категори:ATC код олгогүй эм]]
[[Категори:BioNTech]]
[[Категори:Клиникын туршалга]]
[[Категори:COVID-19-дэ эсэргүү вакцина]]
[[Категори:COVID-19-эй халдабарита үбшэнэй медицинскэ харюу]]
[[Категори:Pfizer]]
[[Категори:2020 ондо нэбтэрүүлэгдэһэн бүтээгдэхүүн]]
[[Категори:РНХ-вакцина]]